Jazz Pharmaceuticals, Inc.

NASDAQ: JAZZ
$99.74
+$0.14 (+0.1%)
Closing price March 31, 2020
Thursday's top analyst upgrades, downgrades and initiations included Akamai Technologies, Anheuser-Busch InBev, Boeing, BP, Comcast, Duke Energy, Gap, Kinder Morgan, Lyft, Occidental Petroleum, Snap,...
Jon C. Ogg
Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa.
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations included ADT, Altria, Biogen, Charles Schwab, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku and Wells Fargo.
Jon C. Ogg
Monday's top analyst upgrades, downgrades and initiations included Amarin, Bank of America, Citigroup, JPMorgan, Liberty SiriusXM, Microsoft, Tesla, TripAdvisor, Twitter and Workday.
Jon C. Ogg
Merrill Lynch research shows significant potential for upside for these stocks when the ISM manufacturing indicators rise, which signs suggest they may do in 2020.
Lee Jackson
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
Trey Thoelcke
The top analyst upgrades, downgrades and initiations for Wednesday included Baidu, BP, Ciena, Chevron, Cree, Exxon Mobile, Home Depot, Medtronic, Nvidia and Urban Outfitters.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
Jon C. Ogg
Stocks were indicated up strong by almost 1% on Wednesday morning for the Dow Jones industrial average, S&P 500 and Nasdaq, quite similar to Tuesday’s gap-up open. This follows last...
Jon C. Ogg
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Wednesday include AECOM, CyberArk, Dillard's, Hasbro, Mattel, Newell, Papa John's, Shopify, Snap and Tesla.
Jon C. Ogg
The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Comcast, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and Walt Disney.
Jon C. Ogg
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
Lee Jackson
Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.
Lee Jackson
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
Lee Jackson